GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Elevance Health Inc (NYSE:ELV) » Definitions » 5-Year Yield-on-Cost %

Elevance Health (Elevance Health) 5-Year Yield-on-Cost % : 2.28 (As of Apr. 29, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Elevance Health 5-Year Yield-on-Cost %?

Elevance Health's yield on cost for the quarter that ended in Mar. 2024 was 2.28.


The historical rank and industry rank for Elevance Health's 5-Year Yield-on-Cost % or its related term are showing as below:

ELV' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.83   Med: 2.51   Max: 4.4
Current: 2.28


During the past 13 years, Elevance Health's highest Yield on Cost was 4.40. The lowest was 1.83. And the median was 2.51.


ELV's 5-Year Yield-on-Cost % is ranked worse than
66.67% of 9 companies
in the Healthcare Plans industry
Industry Median: 3.21 vs ELV: 2.28

Competitive Comparison of Elevance Health's 5-Year Yield-on-Cost %

For the Healthcare Plans subindustry, Elevance Health's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Elevance Health's 5-Year Yield-on-Cost % Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Elevance Health's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Elevance Health's 5-Year Yield-on-Cost % falls into.



Elevance Health 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Elevance Health is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Elevance Health  (NYSE:ELV) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Elevance Health 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Elevance Health's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Elevance Health (Elevance Health) Business Description

Traded in Other Exchanges
Address
220 Virginia Avenue, Indianapolis, IN, USA, 46204
Elevance Health remains one of the leading health insurers in the U.S., providing medical benefits to 48 million medical members as of June 2023. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs such as Medicaid and Medicare Advantage plans, too.
Executives
Blair Williams Todt officer: EVP and Chief Legal Officer 8735 HENDERSON ROAD, TAMPA FL 33625
Ronald W Penczek officer: SVP, Chief Accounting Officer 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Mark Kaye officer: EVP & CFO Designate 7 WORLD TRADE CENTER, 250 GREENWICH ST, NEW YORK NY 10007
Dixon Robert L Jr director 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Gloria M Mccarthy officer: EVP, Office of the CEO WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Kendrick Charles Morgan Jr officer: EVP & President, Commercial 220 VIRGINIA AVE, INDIANAPOLIS IN 46204
Deanna D Strable-soethout director C/O PRINCIPAL FINANCIAL GROUP, 711 HIGH ST., DES MOINES IA 50392
Ramiro G Peru director WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46260
Peter D Haytaian officer: EVP & Pres., Govt. Bus. Div. 220 VIRGINIA AVE, INDIANAPOLIS IN 46204
Susan D. Devore director C/O PREMIER, INC., 13034 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Ryan M. Schneider director 1680 CAPITAL ONE DRIVE, MCLEAN VA 22102
John E Gallina officer: SVP & Chief Accounting Officer 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Julie A Hill director WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Thomas C Zielinski officer: EVP & General Counsel
Jeffrey D. Alter officer: EVP, IngenioRx & Anthem Health 4330 LA JOLLA VILLAGE DRIVE, SUITE 200, SAN DIEGO CA 92122